To examine the targeting ability of the BS−LipoIRI to BxPC3/EGFR pancreatic tumor cells, the cellular uptake of the DiI-labeled LipoIRI or DiI-labeled BS−LipoIRI was examined after incubation of cells at different time intervals. The gene discussed is EGFR; the disease is pancreatic neoplasm.